Search

Your search keyword '"ROSSI G"' showing total 149 results

Search Constraints

Start Over You searched for: Author "ROSSI G" Remove constraint Author: "ROSSI G" Journal annals of oncology Remove constraint Journal: annals of oncology
149 results on '"ROSSI G"'

Search Results

1. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

2. The ECHELON-2 Trial: 5-year results of a randomized, phase III study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma

3. Differences among young adults, adults and elderly chronic myeloid leukemia patients

8. 1048P Molecular predictors of immunotherapy efficacy in lung squamous-cell carcinoma (LSCC): Results from the randomized prospective SQUINT trial

10. 1099P Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients

14. VP1-2022: Pre-specified event driven analysis of Overall Survival (OS) in the OlympiA phase III trial of adjuvant olaparib (OL) in germline BRCA1/2 mutation (gBRCAm) associated breast cancer

15. 90TiP Adjuvant study of amcenestrant (SAR439859) versus tamoxifen for patients with hormone receptor-positive (HR+) early breast cancer (EBC), who have discontinued adjuvant aromatase inhibitor therapy due to treatment-related toxicity (AMEERA-6)

18. 1811P Molecular characterization of epidermal growth factor receptor-mutated (EGFR-m) non-small cell lung cancer (NSCLC) undergoing histological transformation

19. 1276P Deep molecular characterization of never smoker non-small cell lung cancer (NSCLC) patients

23. Differences among young adults, adults and elderly chronic myeloid leukemia patients

26. 1318P Association between soluble PD-L1 and prognosis of non-small cell lung cancer (NSCLC) patients treated with immunotherapy

27. 1216P A circulating exosomal miRNA-based risk score as a predictive biomarker of relapse in early stage non-small cell lung cancer

28. 1277P An exosomal miRNA signature as predictor of benefit from immune checkpoint inhibitors in non-small cell lung cancer

30. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma

39. A phase II study of capecitabine plus concomitant radiation therapy followed by durvalumab (MEDI4736) as preoperative treatment in rectal cancer: PANDORA study

41. Lung cancer predisposition in women with previous breast cancer identified by whole exome sequencing

45. 663TiP - A phase II study of capecitabine plus concomitant radiation therapy followed by durvalumab (MEDI4736) as preoperative treatment in rectal cancer: PANDORA study

48. Appendiceal neuroendocrine tumors: a large multicentre Italian series. Preliminary result

50. Molecular profiling in advanced non-small-cell lung cancer: preliminary data of the Italian observational prospective study

Catalog

Books, media, physical & digital resources